--- title: Buy Xarelto (Rivaroxaban) 20mg Pills Online description: Xarelto (Rivaroxaban) 20mg Pills is a trusted anticoagulant used to prevent blood clots and stroke. Order today for verified quality and secure shipping. type: product language: en url: https://medsforsale.net/buy-xarelto-online-en availability: in_stock price_min: 55.99 price_max: 167.99 currency: USD offers: - name: 10mg x 56 pills price: 55.99 - name: 10mg x 28 pills price: 55.99 - name: 15mg x 28 pills price: 97.99 - name: 15mg x 56 pills price: 139.99 - name: 20mg x 28 pills price: 111.99 - name: 20mg x 56 pills price: 167.99 --- # Buy Xarelto (Rivaroxaban) 20mg Pills Online Xarelto, featuring the active ingredient Rivaroxaban, is a globally recognized anticoagulant developed by Bayer and Janssen Pharmaceuticals. It is essential for preventing deep vein thrombosis, pulmonary embolism, and reducing stroke risk in patients with atrial fibrillation. This medication is intended for adults requiring reliable blood-thinning therapy to maintain cardiovascular health. You can acquire Xarelto through our professional online pharmacy, which stocks the medication in 20mg pills for your safety and convenience. ## Pricing and Options | Dosage | Pack Size | Price (USD) | Price Per Pill | Status | | :--- | :--- | :--- | :--- | :--- | | **10mg** | 56 pills | **$55.99** | $1.00 | In Stock | | **10mg** | 28 pills | **$55.99** | $2.00 | In Stock | | **15mg** | 28 pills | **$97.99** | $3.50 | In Stock | | **15mg** | 56 pills | **$139.99** | $2.50 | In Stock | | **20mg** | 28 pills | **$111.99** | $4.00 | In Stock | | **20mg** | 56 pills | **$167.99** | $3.00 | In Stock | [Buy Now](https://medsforsale.net/buy-xarelto-online-en) ## Introduction Xarelto (rivaroxaban) is an oral anticoagulant indicated to prevent and treat clot-related disorders. It belongs to the class of direct factor Xa inhibitors and is supplied as a 20 mg tablet. The medication is marketed by Bayer and is approved for several cardiovascular indications, including stroke prevention in non-valvular atrial fibrillation, treatment of deep-vein thrombosis (DVT) and pulmonary embolism (PE), and thromboprophylaxis after elective hip or knee replacement surgery. In addition to these primary uses, clinicians sometimes consider Xarelto for off-label situations such as cancer-associated thrombosis, although such applications are not formally approved by the FDA or EMA. ## What is Xarelto? Xarelto is a brand-name prescription drug whose active ingredient is rivaroxaban, a synthetic small-molecule inhibitor of coagulation factor Xa. Developed by Bayer AG and first approved in the United States in 2011, Xarelto quickly became a leading alternative to vitamin K antagonists (e.g., warfarin) because it does not require routine laboratory monitoring. The product is manufactured as a film-coated tablet available in several strengths; the 20 mg strength is the most commonly prescribed dose for acute treatment of venous thromboembolism (VTE) and for long-term stroke prevention in atrial fibrillation. ## How Xarelto Works Rivaroxaban blocks factor Xa, a key enzyme that converts prothrombin to thrombin in the coagulation cascade. By directly inhibiting this step, the drug reduces the generation of fibrin, the protein that forms the structural mesh of blood clots. The onset of anticoagulant activity occurs within 2-4 hours after oral ingestion, and peak plasma concentrations are reached approximately 2-4 hours later. Rivaroxaban’s half-life averages 5-9 hours in younger adults and may extend to 11-13 hours in the elderly, allowing once-daily dosing for many indications. Clearance is roughly split between hepatic metabolism (via CYP3A4/5 and CYP2J2) and renal excretion; therefore, renal function influences dosing adjustments. ## Conditions Treated with Xarelto - **Stroke prevention in non-valvular atrial fibrillation (NVAF).** In NVAF, irregular atrial contractions predispose to blood stasis and clot formation in the left atrial appendage. By inhibiting factor Xa, Xarelto reduces the risk of embolic stroke without the dietary restrictions associated with warfarin. - **Treatment and secondary prevention of deep-vein thrombosis (DVT) and pulmonary embolism (PE).** Following an acute VTE event, Xarelto is started at a higher dose (15 mg twice daily for 21 days) and then transitioned to a maintenance dose (20 mg once daily). This regimen both resolves existing clots and prevents recurrence. - **Thromboprophylaxis after elective hip or knee replacement surgery.** Orthopedic surgery provokes significant tissue trauma and immobilization, raising VTE risk. A once-daily 10 mg dose of Xarelto, started post-operatively, effectively lowers the incidence of postoperative DVT/PE. - **Extended treatment of VTE after the initial 6-month course.** For patients with high-risk features (e.g., active cancer, recurrent VTE), long-term low-dose rivaroxaban (10 mg daily) can be used to maintain anticoagulation while minimizing bleeding risk. ## Off-Label and Investigational Uses of Xarelto - **Cancer-associated thrombosis.** Evidence from the SELECT-D and other phase-II trials suggests rivaroxaban may be comparable to low-molecular-weight heparin for treating VTE in patients with active malignancy. This indication remains off-label; clinicians should weigh the data against bleeding risks and individual patient factors. - **Prevention of arterial thrombotic events in peripheral artery disease (PAD).** Small randomized studies have explored low-dose rivaroxaban (2.5 mg twice daily) combined with aspirin to reduce major adverse limb events. Although promising, the regimen has not received regulatory approval for PAD. - **Left-ventricular thrombus after myocardial infarction.** Case series report successful resolution of mural thrombi with rivaroxaban, but robust trial data are lacking, and the use remains investigational. > **Important:** Off-label use of Xarelto should only occur under direct supervision of a qualified healthcare professional, after an individualized risk-benefit assessment. ## Is Xarelto the Right Medication for You? Xarelto is most suitable for adult patients who require anticoagulation but prefer a regimen without routine INR monitoring. It is especially advantageous for individuals with stable renal function (creatinine clearance ≥ 30 mL/min) and those who can reliably adhere to a once-daily dosing schedule. Conversely, Xarelto is contraindicated in patients with active pathological bleeding, severe hepatic disease associated with coagulopathy, or a known hypersensitivity to rivaroxaban or any tablet component. Caution is advised in patients with moderate to severe renal impairment (CrCl 15-29 mL/min) where dose reduction or alternative agents may be preferred. Pregnant or breastfeeding women should avoid Xarelto because safety data are insufficient. ## Risks, Side Effects, and Interactions ### Common - Gastro-intestinal upset (nausea, dyspepsia) - Mild bruising or epistaxis - Headache These events are usually self-limiting and do not require medical intervention unless they persist. ### Rare - Elevated liver enzymes (transaminase elevations) - Alopecia (hair loss) - Skin rash or pruritus Patients experiencing persistent or bothersome symptoms should discuss them with their prescriber. ### Serious - **Major bleeding** (intracranial hemorrhage, gastrointestinal bleeding, retroperitoneal bleed) - **Spontaneous hemarthrosis** (especially in patients with hemophilia carriers) - **Allergic anaphylaxis** Any sign of severe bleeding-unexpected bruising, blood in stool or urine, persistent coughing up blood, or sudden weakness-demands immediate emergency care. #### Drug-Drug Interactions - **Strong CYP3A4 and P-glycoprotein inhibitors** (e.g., ketoconazole, clarithromycin, ritonavir) increase rivaroxaban exposure and raise bleeding risk; dose reduction or alternative anticoagulation may be required. - **Strong CYP3A4 inducers** (e.g., rifampin, carbamazepine, phenytoin) lower rivaroxaban levels, potentially reducing efficacy; clinicians may need to adjust therapy. - **Antiplatelet agents** (aspirin, clopidogrel) and **non-steroidal anti-inflammatory drugs (NSAIDs)** synergistically increase bleeding risk. #### Drug-Food Interactions - High-fat meals modestly increase rivaroxaban’s bioavailability; the 20 mg tablet should be taken with food to ensure consistent absorption. - No specific dietary restrictions (e.g., vitamin K) are required, unlike warfarin. Patients should avoid excessive alcohol (more than three drinks daily) because it can exacerbate gastric irritation and impair hepatic metabolism. ## Use: Dosing, Missed Dose, Overdose - **Acute DVT/PE treatment:** 15 mg orally twice daily for the first 21 days, then 20 mg once daily with the evening meal. - **Stroke prevention in NVAF:** 20 mg once daily with the evening meal; reduce to 15 mg once daily if creatinine clearance is 15-49 mL/min. - **Post-operative thromboprophylaxis (hip/knee replacement):** 10 mg once daily beginning 6-10 hours after surgery, continued for 10-35 days depending on the procedure. - **Extended VTE prevention:** 10 mg once daily after the initial 6-month treatment course. **Missed dose:** If a dose is forgotten and the scheduled dosing time is less than 12 hours away, skip the missed tablet and resume the regular schedule. Do not double-dose. **Overdose:** In suspected overdose, seek immediate medical attention. Activated charcoal is not useful after absorption. Monitor for signs of bleeding; reversal may be considered with andexanet alfa (FDA-approved) or prothrombin complex concentrate (PCC) in life-threatening situations. **Practical precautions:** - Take the tablet with food to improve absorption. - Avoid driving or operating heavy machinery if you feel dizzy or light-headed. - Store at room temperature, protected from moisture and heat; do not refrigerate. ## FAQ - **What should I do if I travel internationally with Xarelto?** Keep the medication in its original packaging with a copy of the prescription or a doctor’s letter. Carry it in carry-on luggage to avoid temperature extremes in checked baggage. - **Can Xarelto be crushed or split?** The tablet is film-coated and should be swallowed whole. Crushing may alter absorption and increase bleeding risk; consult your prescriber before any modification. - **What inactive ingredients are present in the 20 mg tablet?** Common excipients include lactose monohydrate, magnesium stearate, and silicon dioxide. Patients with severe lactose intolerance should discuss alternatives with their clinician. - **Does Xarelto show up on standard drug tests?** Routine workplace drug screens do not detect rivaroxaban. Specialized laboratory assays are required for therapeutic drug monitoring, which are rarely performed. - **How does Xarelto compare with warfarin regarding monitoring?** Unlike warfarin, Xarelto does not require regular INR checks because its anticoagulant effect is predictable across a wide therapeutic range. - **Is dose adjustment needed for elderly patients?** For patients 75 years or older with normal renal function, the standard dosing generally applies, but clinicians may consider lower maintenance doses if bleeding risk is high. - **Can I use Xarelto while on hormonal contraceptives?** Combined oral contraceptives modestly increase clot risk, but concurrent use of Xarelto is not contraindicated. However, clinicians should evaluate overall thrombotic risk before initiating therapy. - **What is the impact of severe dehydration on Xarelto effectiveness?** Dehydration can reduce plasma volume, potentially increasing drug concentration and bleeding risk. Adequate hydration is advisable, especially during hot weather or intense exercise. - **Are there any known genetic factors influencing Xarelto response?** Polymorphisms in CYP3A4 and P-glycoprotein (ABCB1) genes may slightly affect metabolism, but routine genetic testing is not required in clinical practice. - **How often are the tablets inspected for quality?** Manufacturing facilities follow Good Manufacturing Practice (GMP) standards and undergo regular FDA or EMA inspections to ensure each batch meets potency, purity, and sterility criteria. ## Glossary **Factor Xa inhibitor** : A class of anticoagulants that block the activity of factor Xa, an enzyme essential for converting prothrombin to thrombin, thereby reducing clot formation. **Creatinine clearance (CrCl)** : An estimate of kidney function used to adjust dosages of renally excreted drugs; measured in milliliters per minute. **Andexanet alfa** : A recombinant protein that acts as a decoy receptor for factor Xa inhibitors, used to reverse their anticoagulant effect in emergency bleeding situations. **Pharmacokinetics** : The study of how a drug is absorbed, distributed, metabolized, and eliminated by the body. ## Buying Xarelto from [our online pharmacy](https://medsforsale.net/buy-xarelto-online-en) Patients who encounter cost barriers, limited local pharmacy stock, or insurance coverage gaps can obtain Xarelto through **[our online pharmacy](https://medsforsale.net/buy-xarelto-online-en)**. Our service sources the medication from licensed, internationally accredited suppliers, ensuring that each batch meets stringent quality-control standards equivalent to those required by the FDA and EMA. - **Affordable pricing:** By operating as a pharmacy broker, we negotiate near-manufacturer rates, passing significant savings to the patient without compromising safety. - **Verified quality:** Every shipment is accompanied by a certificate of analysis confirming the correct active ingredient, strength, and purity. - **Discreet, reliable delivery:** Orders are packaged in unmarked parcels and dispatched via secure logistics channels, with standard delivery in 7 days for express or approximately 3 weeks for regular airmail, depending on location. - **Privacy-first approach:** Your personal information is encrypted, and we do not share data with third parties, respecting the confidentiality of your health choices. [our online pharmacy](https://medsforsale.net/buy-xarelto-online-en) is designed to provide a trustworthy, cost-effective avenue for patients who need consistent access to Xarelto, especially when conventional pharmacy options are unavailable or financially prohibitive. ## Disclaimer The information provided about **Xarelto** is intended for general educational purposes only and does not substitute for professional medical advice. All therapeutic decisions, including those concerning off-label applications, should be made under the supervision of a qualified healthcare provider. Readers are assumed to be responsible adults capable of making informed health choices. **[our online pharmacy](https://medsforsale.net/buy-xarelto-online-en)** offers access to **Xarelto** for individuals who may encounter limited availability through conventional pharmacies, prescription-based insurance plans, or who are seeking affordable generic alternatives. Always discuss with your clinician before initiating, modifying, or discontinuing any medication.